BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBI3033 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IBI3033\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07549984-1390@assetmemo.bio
DTSTAMP:20261121T004527Z
DTSTART;VALUE=DATE:20270210
DTEND;VALUE=DATE:20270211
SUMMARY:IBI3033: Phase 1 readout est. (NCT07549984)
DESCRIPTION:IBI3033\, phase 1\, Atopic Dermatitis.\nStudy: A Study of IBI30
 33 in Moderate-to-Severe Atopic Dermatitis\nEstimated primary completion: 
 10 February 2027. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ibi
 3033#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NC
 T07549984
URL:https://assetmemo.bio/drug/ibi3033#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
